Literature DB >> 12140121

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals.

Ruth Salo1, Thomas E Nordahl, Kate Possin, Martin Leamon, David R Gibson, Gantt P Galloway, Neil M Flynn, Avishai Henik, Adolf Pfefferbaum, Edith V Sullivan.   

Abstract

Chronic methamphetamine abuse is associated with disruption of frontostriatal function involving serotonin and dopamine circuitry. Clinically, methamphetamine-dependent (MD) individuals are highly distractible and have difficulty focussing. Here, we used a computerized single-trial version of the Stroop Test to examine selective attention and priming in MD. Subject groups comprised eight MD men (31.7+/-7.2 years of age), who had used methamphetamine for 15.75+/-8.4 years but were currently abstinent for 2-4 months, and 12 controls (35.7+9.7 years of age). Compared with the control group, the MD group exhibited significantly greater interference (P<0.05) despite intact priming. Error rates did not differ between the groups. This preliminary finding of reduced cognitive inhibition in MD individuals is consistent with the distractibility they show clinically. Furthermore, the dissociation between explicit attentional performance and priming effects suggests that some attentional functions are not as affected by long-term methamphetamine use as others.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140121     DOI: 10.1016/s0165-1781(02)00111-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  70 in total

1.  Bayesian neural adjustment of inhibitory control predicts emergence of problem stimulant use.

Authors:  Katia M Harlé; Jennifer L Stewart; Shunan Zhang; Susan F Tapert; Angela J Yu; Martin P Paulus
Journal:  Brain       Date:  2015-09-03       Impact factor: 13.501

2.  Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals.

Authors:  Bankole A Johnson; John D Roache; Nassima Ait-Daoud; Lynda T Wells; Christopher L Wallace; Michael A Dawes; Lei Liu; Xin-Qun Wang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-09-15       Impact factor: 5.067

3.  Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.

Authors:  Antonio Verdejo-García; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2006-11-29       Impact factor: 4.530

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 5.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

6.  Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco.

Authors:  Motohiro Nakajima; Richard Hoffman; Mustafa Al'Absi
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

7.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

8.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

9.  Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study.

Authors:  Ruth Salo; Thomas E Nordahl; Michael H Buonocore; Yutaka Natsuaki; Christy Waters; Charles D Moore; Gantt P Galloway; Martin H Leamon
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

10.  Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.

Authors:  Andy C Dean; Edythe D London; Catherine A Sugar; Christina M R Kitchen; Aimee-Noelle Swanson; Keith G Heinzerling; Ari D Kalechstein; Steven Shoptaw
Journal:  Drug Alcohol Depend       Date:  2009-07-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.